References
  1. Perkin GD. Epilepsy in later childhood and adulthood. In: Warrell DA, Cox TM, Firth JD, editors. Oxford Textbook of Medicine [e-book]. 5th ed. Oxford: Oxford University Press; 2010 [cited 2014 Jan 25]: 24-5-1. Available from: World Health Organization-led HINARI Access to Research in Health programme.
  2. Lowenstein HD. Seizures and Epilepsy. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, editors. Harrison’s Principles of Internal Medicine [e-book]. 18th ed. New York: McGraw-Hill Medical Publishing Division; 2011[Cited 2014 Jan 25]: 369.
  3. Schachter CS. Treatment of seizures. In: Schachter SC, Schomer D, editors. The Comprehensive Evaluation and Treatment of Epilepsy [e-book]. Academic Press; 1997 [cited 2014 Feb 2]: Chapter 3. Available from: World Health Organization-led HINARI Access to Research in Health programme.
  4. Anderson J, Moor C. Anti-epileptic drugs: a guide for the non-neurologist. Clin Med February 2010 10:54-58.
  5. Hussein A, Abdulgalil A, Omer F, Eltoum H, Hamad A, El-Adil O, et al. Correlation between Serum Level of Antiepileptic Drugs and their Side Effects. Oman Med J. 2010 January; 25(1): 17–21.
  6. Stoelting RK, Hillier SC. Pharmacology and Physiology in Anesthetic Practice. 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2005. Chapter 30, Major antiepileptic drugs.
  7. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. London: National Institute for Clinical Excellence; 2004. Clinical Guideline 20.
  8. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ, Jr, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE, Jr, Sachdeo RC, Beydoun A, Glauser TA. Efficacy and tolerability of the new antiepileptic drugs I : treatment of new onset epilepsy: report of the therapeutics and technology assessment subcommittee and quality standards subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2004;62:1252–60. [PubMed]
  9. Theodor W. May. Assessment of adverse effects of antiepileptic drugs: The patient’s view. Epileptology 2013 March; 1(1):46–54.
  10. WHO. International drug monitoring: the role of national centres. Tech Rep Ser WHO1972, no 498.
  11. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet2000; 356:1255–59.
  12. : Robert S. Greenwood. Adverse Effects of Antiepileptic Drugs. Epilepsia. 2000 February; Volume 41, Issue Supplement s2, pages S42–S52.
  13. Piero Perucca, Frank G Gilliam. Adverse effects of antiepileptic drugs. The Lancet Neurology.2012; 11(9): 792-802.
  14. Carreno M, Gil-Nagel A, Sanchez JC, et al. Strategies to detect adverse eff ects of antiepileptic drugs in clinical practice. Epilepsy Behav2008; 13:178–83
  15. Perucca P, Carter J, Vahle V, Gilliam FG. Adverse antiepileptic drug effects: toward a clinically and neurobiologically relevant taxonomy. Neurology 2009; 72(14): 1223-1229.
  16. Yerby, M. S. (2000), Special Considerations for Women with Epilepsy. Pharmacotherapy, 20: 159S–170S.
  17. Isojärvi JI, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllylä VV. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med. 1993 Nov 4;329(19):1383-8.
  18. Franks S. Polycystic Ovary Syndrome. N Engl J Med 1995; 333:853-861.
  19. Herbert AA, Ralston JP. Cutaneous reactions to anticonvulsant medications. J Clin Psychiatry. 2001;62 (Suppl 14):22-26
  20. Llau ME, Viraben R, Montastruc JL. Drug-induced alopecia: review of the literature Therapie (abstr). 1995 Mar-Apr; 50(2):145-50.
  21. Mercke Y, Sheng H, Khan T, Lippmann S. Hair Loss in Psychopharmacology (abstr). Ann Clin Psychiatry 2000; 12:35–42.
  22. Hillemacher T, Bleich S, Kornhuber J, Frieling H. Hair Loss as a Side Effect of Lamotrigine Treatment (abstr)..Am J Psychiatry 2006;163:1451-1451.
  23. Huang Y, Hsieh M, Hsiao P, Sheen J, Yu H, Kuo H, Chen S et al. Alopecia Areata Universalis After Phenobarbital-Induced Anti-Convulsant Hypersensitivity Syndrome (abstr). 2009, Vol. 38, No. 5 , Pages 383-397.
  24. World Health Organization. Definition of health. April 7, 1948. http://www.who.int/about/definition/en/print.html (accessed March 16, 2014).
  25. Ohaeri JU, Awadalla AW, Farah AA. Quality of life in people and their family caregivers. An Arab experience using the short version of the World Health Organization quality of life instrument. Saudi Med J 2009; 30: 1328-1335.\
  26. Penovich PE, Eck KE, Economou VV. Recommendations for the care of women with epilepsy. Cleveland Clinic Journal of Medicine 2004; 71(Suppl 2):S49.